EVE HOLDING INC (EVEX) Stock Fundamental Analysis

NYSE:EVEX • US29970N1046

3.025 USD
+0.03 (+1.17%)
Last: Feb 25, 2026, 11:40 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EVEX. EVEX was compared to 74 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of EVEX have multiple concerns. EVEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • EVEX had negative earnings in the past year.
  • In the past year EVEX has reported a negative cash flow from operations.
  • EVEX had negative earnings in each of the past 5 years.
  • In the past 5 years EVEX always reported negative operating cash flow.
EVEX Yearly Net Income VS EBIT VS OCF VS FCFEVEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • EVEX's Return On Assets of -45.72% is on the low side compared to the rest of the industry. EVEX is outperformed by 83.78% of its industry peers.
  • EVEX has a worse Return On Equity (-109.22%) than 81.08% of its industry peers.
Industry RankSector Rank
ROA -45.72%
ROE -109.22%
ROIC N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVEX Yearly ROA, ROE, ROICEVEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

  • EVEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVEX Yearly Profit, Operating, Gross MarginsEVEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

3

2. Health

2.1 Basic Checks

  • EVEX has more shares outstanding than it did 1 year ago.
  • EVEX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EVEX has a worse debt to assets ratio.
EVEX Yearly Shares OutstandingEVEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EVEX Yearly Total Debt VS Total AssetsEVEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -0.15, we must say that EVEX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.15, EVEX is doing worse than 79.73% of the companies in the same industry.
  • A Debt/Equity ratio of 0.91 indicates that EVEX is somewhat dependend on debt financing.
  • EVEX has a Debt to Equity ratio of 0.91. This is in the lower half of the industry: EVEX underperforms 71.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACCN/A
EVEX Yearly LT Debt VS Equity VS FCFEVEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 5.21 indicates that EVEX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 5.21, EVEX belongs to the best of the industry, outperforming 85.14% of the companies in the same industry.
  • EVEX has a Quick Ratio of 5.21. This indicates that EVEX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of EVEX (5.21) is better than 87.84% of its industry peers.
Industry RankSector Rank
Current Ratio 5.21
Quick Ratio 5.21
EVEX Yearly Current Assets VS Current LiabilitesEVEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

0

3. Growth

3.1 Past

  • The earnings per share for EVEX have decreased strongly by -36.04% in the last year.
EPS 1Y (TTM)-36.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 0.45% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-40.52%
EPS Next 2Y-14.09%
EPS Next 3Y-7.75%
EPS Next 5Y0.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVEX Yearly Revenue VS EstimatesEVEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EVEX Yearly EPS VS EstimatesEVEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

  • EVEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVEX Price Earnings VS Forward Price EarningsEVEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVEX Per share dataEVEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

  • EVEX's earnings are expected to decrease with -7.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.09%
EPS Next 3Y-7.75%

0

5. Dividend

5.1 Amount

  • No dividends for EVEX!.
Industry RankSector Rank
Dividend Yield 0%

EVE HOLDING INC

NYSE:EVEX (2/25/2026, 11:40:02 AM)

3.025

+0.03 (+1.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-04
Earnings (Next)03-18
Inst Owners10.58%
Inst Owner Change7.46%
Ins Owners0.28%
Ins Owner Change0.83%
Market Cap1.05B
Revenue(TTM)N/A
Net Income(TTM)-201.03M
Analysts78.67
Price Target7.4 (144.63%)
Short Float %6.98%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.51%
Min EPS beat(2)-27.33%
Max EPS beat(2)16.31%
EPS beat(4)2
Avg EPS beat(4)-1.82%
Min EPS beat(4)-27.33%
Max EPS beat(4)16.31%
EPS beat(8)6
Avg EPS beat(8)10.77%
EPS beat(12)10
Avg EPS beat(12)12.91%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.87%
PT rev (3m)-6.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.7%
EPS NY rev (1m)0%
EPS NY rev (3m)4.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.72
P/tB 5.72
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.72%
ROE -109.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1564.56%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.21
Quick Ratio 5.21
Altman-Z -0.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1505.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-40.52%
EPS Next 2Y-14.09%
EPS Next 3Y-7.75%
EPS Next 5Y0.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-38.01%
EBIT Next 3Y-2.7%
EBIT Next 5Y14.47%
FCF growth 1Y-100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.85%
OCF growth 3YN/A
OCF growth 5YN/A

EVE HOLDING INC / EVEX FAQ

What is the fundamental rating for EVEX stock?

ChartMill assigns a fundamental rating of 1 / 10 to EVEX.


What is the valuation status for EVEX stock?

ChartMill assigns a valuation rating of 0 / 10 to EVE HOLDING INC (EVEX). This can be considered as Overvalued.


Can you provide the profitability details for EVE HOLDING INC?

EVE HOLDING INC (EVEX) has a profitability rating of 0 / 10.


What is the financial health of EVE HOLDING INC (EVEX) stock?

The financial health rating of EVE HOLDING INC (EVEX) is 3 / 10.


What is the expected EPS growth for EVE HOLDING INC (EVEX) stock?

The Earnings per Share (EPS) of EVE HOLDING INC (EVEX) is expected to decline by -40.52% in the next year.